A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 99
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : rhBMP
Long Form : recombinant human bone morphogenetic protein
No. Year Title Co-occurring Abbreviation
2020 Comparative Clinical Effectiveness and Safety of Bone Morphogenetic Protein Versus Autologous Iliac Crest Bone Graft in Lumbar Fusion: A Meta-analysis and Systematic Review. CI, ICBG, OR
2020 Implantable electrical stimulation bioreactor with liquid crystal polymer-based electrodes for enhanced bone regeneration at mandibular large defects in rabbit. BV/TV, ES, LCP
2020 Non-Autogenous Innovative Reconstruction Method Following Mandibulectomy. ---
2020 Prevention of infection in open fractures: Where are the pendulums now? VAC
2019 Assessment of effects of rhBMP-2 on interbody fusion with a novel rat model. IB, TV
2019 Contained-Delivery Route and the Administration of Postoperative Steroids Following Anterior Cervical Spinal Fusion With Low-dose rhBMP-2 Reduces the Magnitude of Respiratory Compromise. ACDF
2019 Effectiveness of rhBMP-2 association to autogenous, allogeneic, and heterologous bone grafts. CT, VEGF
2019 Longer follow-up continues to reveal no increased risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion. aHR, CI, HR
2019 rhBMP in lumber fusion for lumbar spondylolisthesis: A systematic review and meta-analysis. CNKI, PQDT
10  2019 Titanium mesh associated with rhBMP-2 in alveolar ridge reconstruction. ---
11  2018 Local administration of nuclear factor of activated T cells (NFAT) c1 inhibitor to suppress early resorption and inflammation induced by bone morphogenetic protein-2. ACS, NFAT
12  2018 Superior bone-inducing potential of rhBMP9 compared to rhBMP2. DBBM
13  2017 * Early and Marked Enhancement of New Bone Quality by Alendronate-Loaded Collagen Sponge Combined with Bone Morphogenetic Protein-2 at High Dose: A Long-Term Study in Calvarial Defects in a Rat Model. ALN, ALN-CS
14  2017 A Comparative Analysis of Recombinant Human Bone Morphogenetic Protein-2 with a Demineralized Bone Matrix versus Iliac Crest Bone Graft for Secondary Alveolar Bone Grafts in Patients with Cleft Lip and Palate: Review of 501 Cases. ---
15  2017 An invitro study of fibrin sealant as a carrier system for recombinanthuman bone morphogenetic protein (rhBMP)-9forbonetissue engineering. ---
16  2017 Comparison of recombinant human bone morphogenetic protein-2-infused absorbable collagen sponge, recombinant human bone morphogenetic protein-2-coated tricalcium phosphate, and platelet-rich fibrin-mixed tricalcium phosphate for sinus augmentation in rabbits. ACS, TCP
17  2017 Comparison of Two Porcine Collagen Membranes Combined with rhBMP-2 and rhBMP-9 on Osteoblast Behavior In Vitro. ALP, PDCM, PPCM
18  2017 Effects of Recombinant Human Bone Morphogenetic Protein-2 on Vertical Bone Augmentation in a Canine Model. micro-CT, VBA
19  2017 In vitro evaluation of an injectable biphasic calcium phosphate (BCP) carrier system combined with recombinant human bone morphogenetic protein (rhBMP)-9. BCP, BMP9
20  2017 Minimally Invasive Transforaminal Lumbar Interbody Fusion: Meta-analysis of the Fusion Rates. What is the Optimal Graft Material? MIS-TLIF
21  2017 Recombinant human bone morphogenetic protein (rhBMP)9 induces osteoblast differentiation when combined with demineralized freeze-dried bone allografts (DFDBAs) or biphasic calcium phosphate (BCP). ALP, BCP, BSP, DFDBAs, mRNA, rhBMP9
22  2016 Comparative study suggests that human bone morphogenetic proteins have no influence on the outcome of operative treatment of aseptic clavicle non-unions. ---
23  2016 Effect of sustained release of rhBMP-2 from dried and wet hyaluronic acid hydrogel carriers compared with direct dip coating of rhBMP-2 on peri-implant osteogenesis of dental implants in canine mandibles. BA, BIC, HA
24  2016 The Risk of Cancer With the Use of Recombinant Human Bone Morphogenetic Protein in Spine Fusion. ---
25  2016 Three-Dimensional Upper Lip and Nostril Sill Changes After Cleft Alveolus Reconstruction Using Autologous Bone Grafting Versus Recombinant Human Bone Morphogenetic Protein-2. CT
26  2016 [Bone morphogenetic proteins (BMP): clinical application for reconstruction of bone defects]. BMP
27  2015 Bone Morphogenetic Proteins in Spinal Surgery: What Is the Fusion Rate and Do They Cause Cancer? ---
28  2015 Continuity resection of the mandible after ameloblastoma - feasibility of oral rehabilitation with rhBMP-2 associated to bovine xenograft followed by implant installation. ---
29  2015 Growth factors in orthopaedic surgery: demineralized bone matrix versus recombinant bone morphogenetic proteins. DBM
30  2015 Human bone morphogenetic protein-7 does not counteract aristolochic acid-induced renal toxicity. AA
31  2015 Immediate Effects of Use of Recombinant Bone Morphogenetic Protein in Children Having Spinal Fusion and Refusion Procedures in United States. CI, NIS, OR, SFP
32  2015 Quinoline compound KM11073 enhances BMP-2-dependent osteogenic differentiation of C2C12 cells via activation of p38 signaling and exhibits in vivo bone forming activity. ALP
33  2015 Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model. micro-CT, Scl-Ab
34  2015 Three-Dimensional Changes of Maxilla after Secondary Alveolar Cleft Repair: Differences Between rhBMP-2 and Autologous Iliac Crest Bone Grafting. CT
35  2014 Effect of maxillary alveolar reconstruction on nasal symmetry of cleft lip and palate patients: a study comparing iliac crest bone graft and recombinant human bone morphogenetic protein-2. CT
36  2014 Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig. E.BMP-2, HA, muCT
37  2014 Raspberry ketone promotes the differentiation of C3H10T1/2 stem cells into osteoblasts. ALP, ATRA
38  2014 rhBMP use in cervical spine surgery: associated factors and in-hospital complications. OR
39  2014 The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption. BV, OPG
40  2014 Translational research: The CD34+ cell is crucial for large-volume bone regeneration from the milieu of bone marrow progenitor cells in craniomandibular reconstruction. HU
41  2014 Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database. ACDF, CI, CPT, IQR, OR
42  2014 Use of human recombinant bone morphogenetic protein is associated with increased hospital charges in children with cleft lip and palate having bone graft procedures. ---
43  2013 Primary cancellous bone formation with BMP and micro-chambered beads: experimental study on sheep. DBM, ss-TCP
44  2013 rhBMP-2 with a demineralized bone matrix scaffold versus autologous iliac crest bone graft for alveolar cleft reconstruction. ---
45  2013 Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2). rh-BMP-2
46  2013 Transforaminal lumbar interbody fusion rates in patients using a novel titanium implant and demineralized cancellous allograft bone sponge. ICBG, PEEK, TLIF
47  2012 Clinical application of recombinant human bone morphogenetic protein in cats and dogs: a review of 13 cases. ---
48  2012 Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. HA, micro-CT
49  2012 Repair of critical long bone defects using frozen bone allografts coated with an rhBMP-2-retaining paste. ---
50  2012 Use of BMPs and bisphosphonates in improving bone fracture healing. ---
51  2011 Antibody-mediated osseous regeneration: a novel strategy for bioengineering bone by immobilized anti-bone morphogenetic protein-2 antibodies. Abs, ACS, AMOR
52  2011 Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine. BMP
53  2011 Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation. ACS, BMP, IM, s.c
54  2011 Complications associated with recombinant human bone morphogenetic protein use in pediatric craniocervical arthrodesis. ---
55  2011 Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2. ---
56  2011 Recombinant human bone morphogenetic protein-2 for peri-implant bone regeneration: a case report. ---
57  2011 Surgical therapy of advanced ligature-induced peri-implantitis defects: cone-beam computed tomographic and histological analysis. BIC, EB, HBL, NBM, RBL
58  2011 Treatment with rhBMP12 or rhBMP13 increase the rate and the quality of rat Achilles tendon repair. GDFs
59  2010 Administration of human recombinant bone morphogenetic protein-2 for spine fusion may be associated with transient postoperative renal insufficiency. ---
60  2010 Complications associated with the use of bone morphogenetic protein in pediatric patients. ---
61  2010 Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation. BMC
62  2010 Porcine allograft mandible revitalization using autologous adipose-derived stem cells, bone morphogenetic protein-2, and periosteum. ---
63  2010 Use of recombinant human bone morphogenetic protein-2 as an adjunct for instrumented posterior arthrodesis in the occipital cervical region: An analysis of safety, efficacy, and dosing. ---
64  2010 [Study on osteogenic ability of chitosan/beta-tricalcium phosphate scaffold combined with human bone morphogenetic protein]. CS, TCP
65  2009 Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? ---
66  2009 Patient satisfaction and radiographic outcomes after lumbar spinal fusion without iliac crest bone graft or transverse process fusion. ICBG
67  2009 [Restoration of segmental bone defect by calcium sulfate pellet: experiment with rabbit]. ---
68  2008 Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. PEEK
69  2008 Short-term effects of rhBMP-2-enhanced bone augmentation beyond the skeletal envelope within a titanium cap in rabbit calvarium. ACS
70  2007 Osteopromotion with synthetic oligopeptide-coated bovine bone mineral in vivo. ---
71  2007 Repairing defect and preventing collapse of canine femoral head using titanium implant enhanced by autogenous bone graft and rhBMP-2. ---
72  2007 The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. BMP, FGF
73  2007 The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc: an animal experiment. ---
74  2006 A novel hydroxyapatite fiber mesh as a carrier for recombinant human bone morphogenetic protein-2 enhances bone union in rat posterolateral fusion model. HAM
75  2006 Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. ---
76  2006 Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. BMP
77  2006 Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue. ACS
78  2006 In vivo banking for vascularized autograft bone by intramuscular inoculation of recombinant human bone morphogenetic protein-2 and beta-tricalcium phosphate. TCP
79  2006 The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. beta-TCP
80  2005 Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. ACDF, PEEK
81  2005 Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. BMC, DXA, EP4A, PLA-DX-PEG, polymer
82  2005 Bone morphogenic proteins: applications in spinal surgery. ---
83  2005 Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant. 3DCT, beta-TCP, PLA-DX-PEG
84  2005 The effects of heat on the biological activity of recombinant human bone morphogenetic protein-2. ---
85  2004 Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats. ALP, Ca, FGM, IBM
86  2004 Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: a biomechanics study. ---
87  2004 Treatment of allograft nonunions with recombinant human bone morphogenetic proteins (rhBMP). rhBMPs
88  2003 Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. PGS
89  2002 [Long-term effect of nitric oxide synthase inhibitor on repair of articular cartilage defects repairing]. SMT
90  2001 A new recombinant human bone morphogenetic protein-2 carrier for bone regeneration. ---
91  2001 Anterior cervical interbody fusion with rhBMP-2 and tantalum in a goat model. ---
92  2000 Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. CHO, CrhBMP-2, E. coli, ErhBMP-2
93  2000 Bone-inductive efficacy of recombinant human bone morphogenetic protein-2 expressed in Escherichia coli: an experimental study in rat mandibular defects. ---
94  2000 Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. pI, PK
95  1999 1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells. ALP, rhTGF
96  1999 Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2. TBC
97  1999 Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells. bHLH, RT-PCR
98  1999 Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. ---
99  1996 Recombinant human bone morphogenetic protein (rhBMP) induced heterotopic bone development in vivo and in vitro. ---